Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-03-31): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
0.00%
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+100.00%
vs the sector median at left
OKYO Pharma Limited
Market Cap
$56.02M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.35M
Net Profit Margin
-1507600.00%
TTM Avg
-25517.85%
3Y Avg
-13465.42%
5Y Avg
-10648.78%
Market Cap
$58.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.98M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$57.88M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$59.03M
Net Profit Margin
-86687.50%
TTM Avg
-43373.76%
3Y Avg
-21686.88%
5Y Avg
-14457.92%
Market Cap
$54.50M
Net Profit Margin
-59.97%
TTM Avg
-26.95%
3Y Avg
-5.27%
5Y Avg
-0.58%
Market Cap
$59.78M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-69.82%
5Y Avg
-186.89%
Market Cap
$60.02M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OKYO Pharma Limited (OKYO) | $56.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Talphera, Inc. (TLPH)vs › | $57.35M | -1507600.00% | -25517.85% | -13465.42% | -10648.78% |
| MiNK Therapeutics, Inc. (INKT)vs › | $58.54M | 0.00% | 0.00% | 0.00% | 0.00% |
| Boundless Bio, Inc. (BOLD)vs › | $57.98M | 0.00% | 0.00% | 0.00% | 0.00% |
| PDS Biotechnology Corporation (PDSB)vs › | $57.88M | 0.00% | 0.00% | 0.00% | 0.00% |
| Connect Biopharma Holdings Limited (CNTB)vs › | $59.03M | -86687.50% | -43373.76% | -21686.88% | -14457.92% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $54.50M | -59.97% | -26.95% | -5.27% | -0.58% |
| Adicet Bio, Inc. (ACET)vs › | $59.78M | 0.00% | 0.00% | -69.82% | -186.89% |
| Oncolytics Biotech Inc. (ONCY)vs › | $60.02M | 0.00% | 0.00% | 0.00% | 0.00% |
| Spectral AI, Inc. (MDAI)vs › | $53.62M | -69.27% | -45.15% | -54.32% | -40.58% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-03-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-10-01 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-09-30 | 0.00% |
| 2013-03-31 | 0.00% |
| 2012-09-30 | 0.00% |
| 2012-03-31 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-09-30 | 0.00% |
| 2010-03-31 | 0.00% |
